OFIX
Orthofix Medical Inc
9.20$
-2.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.2% | -2.1% | -2.7% | -1.6% | +2.9% | -7.9% | +1.7% | -0.5% | +2.2% | +4.2% | -1.5% | |
| – | +6.8% | -5.1% | -3.2% | +0.0% | +12.2% | -9.9% | +1.4% | -0.4% | +5.8% | +10.7% | -3.3% | |
| – | -1.7% | -18.6% | -2.2% | +14.0% | +177.0% | -30.4% | +13.2% | +0.5% | +24.4% | +46.6% | -13.7% | |
| – | -1.7% | -18.6% | -2.2% | +14.0% | +177.0% | -30.4% | +13.2% | +0.5% | +24.4% | +46.6% | -13.7% | |
| – | +12.3% | -1.9% | -0.2% | -0.4% | +7.9% | -2.1% | -1.8% | +1.0% | +3.8% | +1.5% | -1.4% | |
| – | +0.2% | -1.4% | -4.1% | -2.0% | -7.9% | -7.9% | -0.9% | +0.6% | -1.0% | +3.2% | +3.7% | |
| – | +0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.9% | -4.0% | -3.9% | -3.5% | -5.5% | -17.8% | -2.9% | -4.1% | -3.8% | -4.7% | -4.9% | |
| – | +12.5% | +2.8% | +0.1% | +1.8% | +14.1% | -6.5% | +3.8% | +3.0% | +2.7% | +12.7% | -1.7% | |
| – | +8.3% | -8.8% | +3.5% | +3.8% | +4.2% | -14.5% | +3.0% | +7.7% | +6.7% | -5.5% | -2.5% | |
| – | +684.3% | -29.2% | +40.9% | +29.0% | -31.7% | +4.1% | -22.7% | +3.2% | +0.4% | -97.1% | +8.7% | |
| – | +9.6% | -2.1% | -11.9% | -6.6% | +3.7% | -7.4% | -0.2% | +11.9% | +15.7% | -6.3% | +16.2% | |
| – | +33.0% | +23.6% | -1.5% | -1.0% | +39.9% | -0.1% | +0.1% | +0.1% | +0.1% | +40.6% | +0.1% | |
| – | -2.7% | -4.7% | -4.3% | -3.7% | -4.3% | -8.9% | +0.0% | -3.5% | +1.7% | -3.3% | -1.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +1.4% | +0.7% | +1.2% | +0.6% | +1.3% | +0.8% | +0.7% | +0.6% | +1.1% | +1.1% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.